The present invention relates to pharmaceutical formulations comprising specific hydrazidomycin compounds. Since said hydrazidomycin compounds show cytotoxic activities, the present invention further relates to said hydrazidomycin compounds for use in medicine, in particular in the treatment of proliferative disorders.
本发明涉及含有特定的
肼唑霉素化合物的药物制剂。由于这些
肼唑霉素化合物表现出细胞毒性活性,因此本发明进一步涉及将这些
肼唑霉素化合物用于医学,特别是用于治疗增生性疾病。